Menb Vaccines Are Safe However As With Any Vaccine Side Effects Can Occur
Available data suggest that MenB vaccines are safe. More than half of the people who get a MenB vaccine have mild problems following vaccination:
- Soreness, redness, or swelling where the shot was given
- Feeling tired
- Fever or chills
- Nausea or diarrhea
If they occur, these reactions usually get better on their own within 3 to 5 days. Serious reactions are possible, but rare.
Teens are more likely to have side effects after MenB vaccination compared to other vaccines given to preteens and teens. Those other vaccines include HPV, MenACWY, and Tdap vaccines.
CDC continually monitors the safety of all vaccines, including MenB vaccines. For more information, view the Serogroup B Meningococcal Vaccine Information Statement.
Common And Local Adverse Events
Conjugate meningococcal vaccines
Injection site reactions occur in up to 59% of vaccinees. Fever is reported in up to 5% of recipients and systemic reactions, such as headache and malaise, are reported in up to 60% of recipients.
Mild reactions, including injection site reactions , occur in up to 50% of vaccine recipients. Irritability occurs in up to 80% of infants and fever in up to 9% when other vaccines were administered. Headaches and malaise occur in up to 10% of older children and adults. These reactions last no more than a few days.
Serogroup B Meningococcal vaccines
Solicited local and systemic reactions have been commonly reported in clinical trials and include injection site tenderness, induration, sleepiness and irritability. Higher rates of fever have been observed with simultaneous administration of 4CMenB vaccine and routine infant vaccines therefore, routine prophylactic administration of acetaminophen or separating 4CMenB vaccination from routine vaccination schedule has been proposed for preventing fever in infants and children up to three years of age.
Solicited local and systemic reactions have been commonly reported in clinical trials and include injection site tenderness, induration and irritability.
Meningococcal C Conjugate Vaccine
NeisVac-C is a meningococcal conjugate vaccine to protect against meningococcal group C only.
This can be used to protect babies under the age of 9 months. Babies who are less than 9 months of age need three doses to be protected. Children over 9 months of age and adults should be given the ACWY vaccine, Menactra.
The NeisVac-C vaccine is funded for children aged under 9 months with a medical condition that increases their risk of invasive meningococcal disease AND is listed on the Pharmaceutical Schedule. Refer to the Immunisation Handbookfor more details.
NeisVac-C is also available as a purchased vaccine through your family doctor. The cost is approximately $98 per dose.
For more advice on vaccines and their availability, talk to your family doctor, call the free Immunisation Advisory Centre helpline 0800 IMMUNE , or see the Immunisation Handbook.
Don’t Miss: Cost Of Shingles Vaccine At Cvs
Where Can I Find These Vaccines
Your doctor is usually the best place to receive recommended vaccines for you or your child. These vaccines are part of the routine childhood immunization schedule. Therefore, vaccines for children and teens are regularly available at
- Pediatric and family practice offices
- Community health clinics
If your doctor does not have these vaccines for adults, ask for a referral.
Vaccines may also be available at
- Health departments
- Other community locations, such as schools and religious centers
You can also contact your state health department to learn more about where to get vaccines in your community.
When receiving any vaccine, ask the provider to record the vaccine in the state or local vaccine registry, if available. This helps providers at future visits know what vaccines you or your child have already received.
Menveo Nimenrix And Menactra
The product information for Menveo, Nimenrix and Menactra states that vaccine should be administered as a single dose to people aged 2 years.
ATAGI recommends that these vaccines can be given in a 2- or 3-dose primary schedule to people aged 2 years who are at increased risk of invasive meningococcal disease according to Table. Recommendations for MenACWY vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease.
Read Also: Where To Get Tdap Vaccine Cvs
Most Health Insurance Plans Pay For Menb Vaccination For Teens And Young Adults
Most health plans must cover CDC-recommended vaccines with no out-of-pocket costs if an in-network healthcare provider administers the vaccine. Check with your insurance provider for details on whether there is any cost to you for this vaccine.
The Vaccines for Children, or VFC, program provides vaccines for children 18 years old and younger who are
- Not insured
- American Indian or Alaska Native
Parents can find a VFC provider by contacting their local health department. VFC will cover the cost of MenB vaccination for those
- 16 through 18 years old
- 10 through 18 years old at increased risk due to a medical condition
- 10 through 18 years old identified as being at increased risk due to a serogroup B meningococcal disease outbreak
What Can Students And Employees Do
Get vaccinated. Make sure you were vaccinated less than three years ago and, if not, get a booster. This vaccine loses effectiveness after a few years. Getting vaccinated can help break the spread of the bacteria that causes meningococcal disease from person to person.
Take steps to prevent the spread of the bacteria by limiting close, intimate contact with others and avoid sharing items that expose you to the saliva of others, such as sharing drinking containers, eating utensils or food, and pipes, cigarettes, bongs, joints or hookahs.
Anyone with symptoms of meningococcal disease should seek medical attention. If symptoms worsen, continue to seek medical attention even if you saw a doctor within several hours. During business hours, students can access the CSU Health Network by calling a meningococcal disease line at 970-491-2147 or visiting the Hartshorn Building. After hours or in an emergency, students or employees should seek emergency care at local hospitals.
You May Like: Cheapest Shingrix Vaccine
Serogroup B Meningococcal Or Menb Vaccines
GlaxoSmithKline formulates each 0.5-mL dose of Bexsero® to contain:
- 50 µg each of recombinant proteins Neisserial adhesin A , Neisserial Heparin Binding Antigen , and factor H binding protein
- 25 µg of Outer Membrane Vesicles
- 5 milligrams aluminum hydroxide
- 125 mg sodium chloride
- 10 mg sucrose at pH 6.4 6.7
Each dose contains less than 0.01 µg kanamycin .
Pfizer formulates each 0.5-mL dose of Trumenba® to contain:
- 60 µg each of 2 lipidated fHBP variants
- 0.018 mg of polysorbate 80
- 0.25 mg of Al³+
- 10 millimolar histidine buffered saline at pH 6.0
Complications Of Meningococcal Disease
Meningococcal infections can progress rapidly to serious disease or death in previously healthy people. The overall mortality risk for IMD is high , even if the person receives appropriate antibiotic therapy.
Around one-third of children and adolescents who survive IMD develop permanent sequelae. These can include:84
- limb deformity
- neurologic deficits
Around 3040% of people who survive IMD have long-term consequences or disabilities. Patients and caregivers can also have psychological symptoms due to these sequelae.92-94
Also Check: Cvs Tdap
Economic Evaluations Of Meningococcal Disease And Vaccines
Data on the cost of vaccine and financial burden of disease have been published from Africa and some industrialized countries where a vaccine has been introduced. Limited data on meningococcal carriage and incidence are available from other countries, especially in Asia, and thus cost effectiveness cannot currently be accurately determined for these countries.
One study in Burkina Faso found that the cost per household of a case of meningococcal disease in Sub-Saharan Africa is US$ 90, with additional US$154 expenditure if sequelae of the disease occur. The urban cost is more than 200% higher than the rural cost. An idea of the overall burden of disease can be gaged from the total cost of the 20062007 outbreak, in Burkina Faso which was US$ 9.4 million, 7.1M borne by the public health system and 2.3M borne by households which comprised 34% of the GDP capita. The Meningitis Vaccine Project has the potential to:
Prevent 123 000 deaths by 2018
Prevent permanent disability in 287 000 children and adults
Prevent 11 million DALYs lost
Save approximately $99.7 million in medical costs for diagnosis and treatment
Nature Of The Disease
Meningococcal disease is caused by the bacterium Neisseria meningitidis. The bacterium is commonly known as meningococcus.
There are 13 known meningococcal serogroups, distinguished by differences in surface polysaccharides of the bacteriums outer membrane capsule. Globally, serogroups A, B, C, W and Y most commonly cause disease.
Read Also: Tdap Shots Cvs
Meningococcal Conjugate Or Menacwy Vaccines
Sanofi Pasteur formulates each 0.5-milliliter dose of Menactra® in sodium phosphate buffered isotonic sodium chloride solution. Each dose contains 4 micrograms each of meningococcal A, C, W, and Y polysaccharides conjugated to approximately 48 µg of diphtheria toxoid protein carrier. It does not contain a preservative or an adjuvant. The manufacturer supplies it as a liquid in a single-dose vial.
GlaxoSmithKline formulates each 0.5-mL dose of Menveo® to consist of 2 portions:
- 10 µg of lyophilized meningococcal serogroup A capsular polysaccharide conjugated to CRM197
- 5 g each of capsular polysaccharide of serogroup C, W, and Y conjugated to CRM197 in 0.5 mL of phosphate buffered saline
Vaccine providers reconstitute the lyophilized MenA component with the MenCWY liquid component before injection. It does not contain a preservative or an adjuvant.
Sanofi Pasteur formulates each 0.5-milliliter dose of MenQuadfi® to contain 10 µg each of meningococcal A, C, W, and Y polysaccharides conjugated to approximately 55 µg of tetanus toxoid protein carrier. It does not contain a preservative or an adjuvant. The manufacturer supplies it as a liquid in a single-dose vial.
What Are The Side Effects Of Meningococcal Vaccines
Mild side effects happen in about half those who get the vaccine. They may include redness or pain where the skin was injected. These side effects last no longer than 1 or 2 days.
Serious side effects are rare and can include high fever, weakness, and changes in behavior.
Severe allergic reactions may happen within minutes or hours of having the vaccination. These are signs of an allergic reaction:
Recommended Reading: Cvs Tdap Vaccine Schedule
People Without A Spleen Or Whose Spleen Does Not Work Properly
If you do not have a spleen, or your spleen does not work properly, or you have a weakened immune system then it is likely to be recommended to you that you receive the MenB and the MenACWY vaccines. The timing of your vaccines will depend on your age. Your doctor will be able to advise you in more detail regarding this.
Is Bacterial Meningitis Airborne Or Droplet Precautions
4/5Meningococcal meningitisdroplet precautionsmeningitis
Also asked, is bacterial meningitis airborne or droplet?
Bacterial meningitis is NOT spread through casual contact or the airborne route however, some bacteria can be spread by close contact with respiratory droplets .
Furthermore, what is the difference between droplet and airborne? Airborne spread happens when a germ floats through the air after a person talks, coughs, or sneezes. Droplet spread happens when germs traveling inside droplets that are coughed or sneezed from a sick person enter the eyes, nose, or mouth of another person.
Also question is, is Neisseria meningitidis airborne?
Neisseria meningitidis bacteria are spread from person to person by inhaling airborne droplets when an infected person coughs or sneezes or just by close contact. In many cases, the bacteria is spread by infected individuals that are carriers of Neisseria meningitidis, but do not show any symptoms.
Is measles airborne or droplet precaution?
Diseases requiring airborne precautions include, but are not limited to: Measles, Severe Acute Respiratory Syndrome , Varicella , and Mycobacterium tuberculosis. Airborne precautions apply to patients known or suspected to be infected with microorganisms transmitted by airborne droplet nuclei.
Don’t Miss: Tdap Cvs
Is Meningococcal Disease Serious
Meningococcal meningitis and bloodstream infections can be very serious, even deadly. The infections progress quickly. Someone can go from being healthy to very ill in 48 hours or less. Even if they get treatment, about 10 to 15 out of 100 people with meningococcal disease will die from it. Long-term disabilities from having meningococcal disease include loss of limbs, deafness, nervous system problems, and brain damage.
Meningococcal Vaccine: Canadian Immunization Guide
For health professionals
Latest partial content update :
: The chapter has been updated to align with the National Advisory Committee on Immunization Statement : The Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B Vaccine for the Prevention of Meningococcal B Disease.
MenB-fHBP vaccine may be considered as an option for use in individuals 10 years of age and older in situations when a serogroup B meningococcal vaccine should be offered:
MenB-fHBP vaccine may be considered as an option for individuals 1025 years of age who are not at higher risk of meningococcal disease than the general population, but who wish to reduce their risk of invasive serogroup B meningococcal disease.
Last complete chapter revision: May 2015
Read Also: Tdap Shot Cvs
Problems That Could Happen After Getting Any Injected Vaccine
- People sometimes faint after medical procedures, including vaccination. Sitting or lying down for about 15 minutes can help prevent fainting, and injuries caused by a fall. Tell the provider if you or your child feel dizzy, have vision changes, or have ringing in the ears.
- As with any medicine, there is a very remote chance of a vaccine causing a severe allergic reaction, other serious injury, or death.
Medical Definition Of Meningitis Vaccine
- Medical Editor: Jay W. Marks, MD
Reviewed on 6/3/2021
Meningitis vaccine: This term usually refers to a vaccine used to prevent meningococcal meningitis, an inflammation of the membranes that cover the brain and spinal cord due to bacterial infection by Neisseria meningitidis.
The CDC’s Advisory Committee on Immunization Practices in 1999 made a unanimous recommendation that college freshmen be vaccinated against this type of bacterial meningitis.
A study published in The Journal of the American Medical Association showed that college students who live on campus have triple the risk of acquiring meningococcal infection compared with their peers who live off-campus. Among the factors cited for a higher risk of the disease on campus were the relative crowding associated with dormitory residence, alcohol-related behaviors, and exposure to tobacco smoke. The same factors make young adults who are military recruits at higher risk for meningococcal meningitis and provide the basis for recommendations that they, too, receive the vaccine.
The vaccine is generally effective against most strains of the bacteria affecting college students in the U.S. . Protection by the vaccine lasts at least 3 years. A booster is not needed in college
The vaccine has been well-tested and is safe. Side effects are mild, mainly low-grade fever and pain and tenderness at the site of the immunization for a day or so afterwards.
Recommended Reading: Cheapest Shingles Shot
Is It Too Late To Get Vaccinated
The answer to this question isnt so clear-cut. If you have an unvaccinated teen headed off to college, there is still time for them to get their vaccines. Your child may also need another shot if they had the vaccine as a preteen. Meningitis vaccines are thought to only last for about five years, according to the Center for Young Womens Health.
Adults can also get the meningitis vaccine if their doctors recommend it. Certain situations can warrant the use of meningitis vaccinations. Examples include spleen removal, going to military camp, or traveling overseas.
Risk By Age Group And By Aboriginal And Torres Strait Islander Status
Children aged < 2 years
Children aged < 2 years have the highest incidence of meningococcal cases. The disease occurs most often in infants aged 35 months.
Adolescents aged 1519 years
A high number of meningococcal disease cases occurs among adolescents and young adults aged 1524 years, with peak rates of disease occurring in 1820-year-olds. Adolescents and young adults have the highest rate of meningococcal carriage and are thought to play an important role in transmitting the bacteria in a community.4
Adolescents and young adults in this age bracket who have a higher risk of acquiring the meningococcal bacteria are:
- people who live in close quarters, such as new military recruits and students living in residential accommodation
- people who have prolonged contact with a person who is carrying meningococcal bacteria5-7
- people who are smokers8-10
Aboriginal and/or Torres Strait Islander people
Aboriginal and Torres Strait Islander people have much higher incidence rates of meningococcal disease than non-Indigenous Australians.96 This is particularly among children aged < 15 years for the 2 most common meningococcal serogroups: B and W.
Also Check: Pertussis Vaccine Cvs
Who Is Most At Risk
Anyone can potentially get meningococcal disease, but, it is more common in:
- babies and young children
- people with a weak immune system for example those having chemotherapy treatment or have HIV
- close contacts of meningococcal disease cases
- those having other respiratory infections
- people living in shared accommodation such as halls of residence , boarding school and hostels
- those living in overcrowded housing
- those exposed to tobacco smoke.
It is possible to get meningitis more than once.
Who Should Not Get A Meningococcal Vaccine
Your preteen or teen shouldn’t get the meningococcal vaccine if they:
- Has had a severe, life-threatening allergic reaction to a meningococcal vaccine before or to any vaccine component
- Is moderately or severely ill
- Has ever had Guillain-Barre syndrome
Pregnant women can get the meningococcal vaccine, but it’s only recommended for those with certain immune problems or those likely to be exposed to meningitis. With the newer MCV4 and MenB vaccines, there hasn’t been as much study in pregnant women compared to the MPSV4 vaccine.
Also Check: Can I Get A Tdap Shot At Cvs